Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 18Breast Neoplasms 2Anemia 2Myofibroma 1Fibroma 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Imatinib Mesylate 2telapristone acetate 1seclidemstat 1Uterine Myomectomy 1Triamcinolone Acetonide 1Topotecan 1Specimen Handling 1Sodium Chloride 1Sirolimus 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hydroxyurea 1Cyclophosphamide 1CTLA-4 Antigen 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fibroma × telapristone acetate × Clear all
NCT02323646 2019-06-25

Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids

Repros Therapeutics Inc.

Phase 2 Completed
42 enrolled 22 charts

Fibroma, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡